OPK
OPKO HEALTH, INC.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$1.61
+5.23%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.25x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.01x
- Price / sales
- 2.04x
- Price / cash flow
- -9.74x
Enterprise value
- Enterprise value
- $1.3B
- EV / sales
- 2.20x
- EV / EBITDA
- 25.91x
- EV / EBIT
- -8.63x
- Market cap
- $1.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026